{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2001"],"condition":["Dukes'C colorectal cancer which is removed curatively and surgically"],"disease":["Dukes'c Colorectal Cancer Which Is Removed Curatively And Surgically"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2609501"],"location":["Japan"],"study_start_month":["11"],"repository":["ECRIN MDR"],"study_status":["Active, not recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Role of Thymidine Phosphorylase(TP), Dihydropyrimidine Dehydrogenase(DPD)and Thymidylate synthase(TS)for Predicting the Prognosis and Therapeutic Effects of Doxifluridine, An Intermediate form of Capecitabine, in adjuvant therapy for postoperative Node positive colorectal cancer(DukesC); Findings from a multicenter Phase2 trial.","description":"Interventions: chemotherapy(Doxifluridine:5’-DFUR)\nPrimary outcome(s): Disease-free survival\nStudy Design: Single arm Non-randomized","dates":{"creation":"2001-11-15"},"accession":"2609501","cross_references":{"Japan Primary Registries Network":["JPRN-C000000077"]}}